By Colin Kellaher Shares of BioVie Inc. rose sharply in premarket trading Tuesday after the clinical-stage biopharmaceutical company reported positive results from a pair of Phase 2 studies assessing the
Roche Holding AG said Monday that Phase 3 Graduate studies of gantenerumab, for treatment of early Alzheimer’s disease, failed to meet its primary endpoints. The Swiss pharma company ROG, -3.72% Read more A study published in July 2022 in Neurology, a journal from the American Academy of Neurology, suggests that eating whole foods might decrease dementia risk. The research was done on 72,083 adults over Read more Wana Brands founder and CEO Nancy Whiteman is stepping up her charitable activities with $3 million for cannabis and psychedelic medicine research at Johns Hopkins University — the largest donation Read more We all understand that no magic elixir can stop or even slow the human brain or skeletal muscles from aging. But is that true? After two decades of research with Read more A couple of years ago I bought a big book of crosswords and started doing one every day. I found something peculiar. With each crossword, I would initially get stuck Read more Where is the hysteria? Where is the mass panic? Where is the preening virtue signaling? Why aren’t people on Twitter showing off by screaming “granny killer!” at anyone who disagrees Read more There may not be a “magic pill,” but there are ways to stave off dementia and improve your brain health, one scientist says. Crossword puzzles and Sudoku are helpful in Read more Biogen Inc. BIIB, -1.93% and Eisai Co. Ltd. 4523, +3.57% are getting closer to a possible approval of their new treatment for Alzheimer’s disease, with plans to submit the drug Read more The things to remember about dementia are that it is absolutely horrible for you and everyone around you; it’s a high probability; and when it comes to fighting it or Read more
Roche says Phase 3 studies for Alzheimer’s drug failed to meet primary endpoints
Try these simple rules for making food choices that could reduce your risk of dementia
Wana Brands CEO makes seven-figure donation to fund cannabis research
What neuroscientists have learned about rejuvenating the aging brain—and what you can do too
Want to slow, delay or reverse dementia? Try this classic game.
When will we care as much about Alzheimer’s as we did about COVID-19?
4 things you can do to fight dementia and improve your memory
Biogen and Eisai make plans to take another Alzheimer’s drug to the FDA
People who do this one thing have HALF the Alzheimer’s risk